# A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

> **NCT05790889** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Oxford** · enrollment: 480 (estimated)

## Conditions studied

- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** Rabies vaccine
- **BIOLOGICAL:** RH5.1 10μg adjuvated with 50μg Matrix-M
- **BIOLOGICAL:** RH5.2 5μg adjuvated with 50μg Matrix-M

## Key facts

- **NCT ID:** NCT05790889
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-03
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05790889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05790889, "A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05790889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*